Skip to main content

Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Arcutis Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
12 filings
5 insiders, $2.30M in total
Insiders trading
5
Net value
−$2.30M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Arcutis Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Arcutis Biotherapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Matsuda MasaruSee Remarks112,508Sep 18, 20269
Welgus Howard G.Director35,841Sep 17, 202613
Curran TerrieDirector23,526Aug 28, 20263
Burnett PatrickSee Remarks117,592Aug 21, 202612
Watanabe Todd FranklinSee Remarks717,203Aug 5, 20268
Peetz ChristopherDirector4,315Jul 17, 20261
Lin Sue-JeanDirector27,567Jun 17, 20263
Heron Patrick JDirector32,213Jun 12, 20261
Leonard Keith RDirector27,901Jun 9, 20263
Gilbert Halley EDirector27,901Jun 9, 20262
Munshi AmitDirector9,799Jun 9, 20262
Krishnamohan NehaDirector27,901Jun 9, 20262
Vairavan LathaSVP Chief Financial Officer85,978May 13, 20265
Edwards Larry ToddSee Remarks175,178Mar 3, 20264
Chaudhuri BhaskarDirector867,826Jun 16, 20250
Topper David JosephChief Financial Officer182,774Apr 3, 20250
Moore Matthew RichardSVP and Chief Business Officer145,505May 3, 20240
Smither John WChief Financial Officer11,365Feb 15, 20240
Topper James N10% Owner8,764,232Oct 26, 20230
Frazier Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.L.C.10% Owner8,764,232Oct 26, 20230
Osborne David WChief Technical Officer268,854Mar 8, 20230
Turney Patricia A.SVP, Operations62,862Mar 8, 20230
Lock Kenneth A.Chief Commercial Officer63,429Mar 8, 20230
Burrows Scott LChief Financial Officer59,115Mar 8, 20230
OrbiMed Advisors LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital GP VII LLC10% Owner415,142IndirectJun 28, 20220
Turner Joseph LDirector4,312Jun 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 5, 2025 (view filing)Nov 32 daysWelgus Howard G.DirectorSSale−10.0K$25.27−$252.7K−10.0%89.7K after10b5-1
Nov 5, 2025 (view filing)Nov 32 daysMatsuda MasaruSee RemarksSSale−7.21K$24.71−$178.1K−4.5%154.0K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 3-52 daysBurnett PatrickSee RemarksSSale−6.49K$24.12−$156.5K−6.2%98.3K after3 lots10b5-1
Oct 30, 2025 (view filing)Oct 282 daysWatanabe Todd FranklinSee RemarksSSale−40.0K$25.03−$1.00M−4.7%806.4K after10b5-1
Oct 6, 2025 (view filing)Oct 24 daysEdwards Larry ToddSee RemarksSSale−4.50K$20.04−$90.3K−2.5%179.3K after2 lots10b5-1
Oct 3, 2025 (view filing)Oct 1-22 daysWatanabe Todd FranklinSee RemarksSSale−45.0K$19.66−$884.7K−5.0%846.4K after3 lots10b5-1
Oct 3, 2025 (view filing)Oct 12 daysWelgus Howard G.DirectorSSale−10.0K$18.92−$189.2K−9.1%99.7K after2 lots10b5-1
Sep 10, 2025 (view filing)Sep 8-92 daysWatanabe Todd FranklinSee RemarksSSale−10.1K$17.54−$177.7K−1.1%891.4K after2 lots10b5-1
Sep 8, 2025 (view filing)Sep 44 daysMatsuda MasaruSee RemarksSSale−36.1K$16.16−$583.9K−18.3%161.2K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysWelgus Howard G.DirectorSSale−10.0K$15.64−$156.4K−9.1%100.2K after10b5-1
Aug 21, 2025 (view filing)Aug 19-212 daysBurnett PatrickSee RemarksSSale−4.19K$15.82−$66.2K−3.8%104.8K after2 lots10b5-1
Aug 12, 2025 (view filing)Aug 84 daysBurnett PatrickSee RemarksSSale−3.85K$14.03−$54.0K−3.4%109.0K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayWatanabe Todd FranklinSee RemarksSSale−11.5K$14.33−$165.5K−1.3%901.6K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayBurnett PatrickSee RemarksSSale−2.62K$14.33−$37.6K−2.3%112.8K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayVairavan LathaSVP Chief Financial OfficerSSale−89$14.33−$1.28K−0.1%65.0K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayMatsuda MasaruSee RemarksSSale−6.33K$14.33−$90.7K−3.1%197.4K after10b5-1
Aug 5, 2025 (view filing)Aug 14 daysWelgus Howard G.DirectorSSale−10.0K$14.30−$143.0K−9.1%100.2K after2 lots10b5-1
Jul 14, 2025 (view filing)Jul 10-144 daysBurnett PatrickSee RemarksSSale−28.8K$15.05−$432.8K−19.9%115.5K after2 lots10b5-1
Jul 2, 2025 (view filing)Jul 11 dayWelgus Howard G.DirectorSSale−9.21K$13.84−$127.4K−8.4%100.2K after10b5-1
Jun 20, 2025 (view filing)Jun 182 daysWelgus Howard G.DirectorSSale−10.1K$13.37−$135.6K−8.5%109.4K after10b5-1
Jun 17, 2025 (view filing)Jun 134 daysHeron Patrick JDirectorPPurchase+2.65K$13.08+$34.6K+10.7%27.4K after
Jun 6, 2025 (view filing)Jun 4-52 daysHeron Patrick JDirectorPPurchase+2.27K$13.34+$30.2K+10.1%24.8K after2 lots
May 29, 2025 (view filing)May 281 dayMatsuda MasaruSee RemarksSSale−1.80K$13.78−$24.8K−0.9%202.6K after10b5-1
May 23, 2025 (view filing)May 21-222 daysHeron Patrick JDirectorPPurchase+5.04K$13.66+$68.8K+28.8%22.5K after2 lots
May 20, 2025 (view filing)May 191 dayEdwards Larry ToddSee RemarksSSale−7.45K$14.07−$104.8K−3.9%183.1K after10b5-1
May 19, 2025 (view filing)May 154 daysHeron Patrick JDirectorPPurchase+2.52K$13.62+$34.3K+16.8%17.5K after
May 15, 2025 (view filing)May 13-142 daysHeron Patrick JDirectorPPurchase+8.67K$13.76+$119.4K+137.7%15.0K after2 lots
May 13, 2025 (view filing)May 94 daysHeron Patrick JDirectorPPurchase+6.30K$13.60+$85.7KNew position6.30K after
May 9, 2025 (view filing)May 81 dayBurnett PatrickSee RemarksSSale−3.87K$13.59−$52.6K−3.2%115.5K after10b5-1
May 5, 2025 (view filing)May 23 daysMatsuda MasaruSee RemarksSSale−5.03K$15.20−$76.5K−2.4%204.4K after10b5-1
May 5, 2025 (view filing)May 23 daysWatanabe Todd FranklinSee RemarksSSale−11.4K$15.19−$173.9K−1.2%913.8K after10b5-1
May 5, 2025 (view filing)May 23 daysBurnett PatrickSee RemarksSSale−2.60K$15.19−$39.4K−2.1%119.3K after10b5-1
May 5, 2025 (view filing)May 14 daysWelgus Howard G.DirectorSSale−10.0K$14.64−$146.4K−8.2%111.9K after10b5-1
Apr 3, 2025 (view filing)Apr 12 daysWelgus Howard G.DirectorSSale−10.0K$15.12−$151.2K−7.6%121.9K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayTopper David JosephChief Financial OfficerSSale−9.60K$15.80−$151.7K−5.0%182.8K after10b5-1
Mar 26, 2025 (view filing)Mar 24-252 daysWatanabe Todd FranklinSee RemarksSSale−3.67K$17.54−$64.4K−0.4%925.2K after2 lots10b5-1
Mar 20, 2025 (view filing)Mar 173 daysLateWatanabe Todd FranklinSee RemarksSSale−1.20K$17.61−$21.1K−0.1%928.9K after10b5-1
Mar 17, 2025 (view filing)Mar 13-144 daysBurnett PatrickSee RemarksSSale−61.4K$14.99−$920.7K−33.5%121.9K after3 lots10b5-1
Mar 4, 2025 (view filing)Mar 3-41 dayBurnett PatrickSee RemarksSSale−3.77K$13.09−$49.4K−2.2%166.1K after2 lots10b5-1
Mar 4, 2025 (view filing)Mar 3-41 dayWatanabe Todd FranklinSee RemarksSSale−25.0K$13.07−$327.0K−2.6%930.1K after2 lots10b5-1
Mar 4, 2025 (view filing)Mar 31 dayWelgus Howard G.DirectorSSale−10.0K$13.00−$130.0K−7.0%131.9K after10b5-1
Mar 4, 2025 (view filing)Mar 31 dayMatsuda MasaruSee RemarksSSale−3.26K$13.03−$42.5K−1.5%209.4K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayMatsuda MasaruSee RemarksSSale−8.34K$12.70−$105.9K−4.5%178.7K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayWatanabe Todd FranklinSee RemarksSSale−19.3K$12.70−$245.1K−2.3%804.1K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayWelgus Howard G.DirectorSSale−10.0K$12.71−$127.1K−6.6%141.9K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayBurnett PatrickSee RemarksSSale−12.1K$12.70−$153.9K−9.5%114.9K after10b5-1
Feb 4, 2025 (view filing)Feb 31 dayEdwards Larry ToddSee RemarksSSale−2.17K$12.70−$27.6K−1.6%135.6K after10b5-1
Jan 6, 2025 (view filing)Jan 24 daysWelgus Howard G.DirectorSSale−10.0K$14.67−$146.7K−6.2%151.9K after10b5-1
Dec 31, 2024 (view filing)Dec 31Same dayBurnett PatrickSee RemarksSSale−1.69K$14.00−$23.7K−1.3%127.0K after10b5-1
Dec 23, 2024 (view filing)Dec 203 daysWatanabe Todd FranklinSee RemarksSSale−15.0K$15.17−$227.6K−1.8%823.4K after10b5-1